Did you know tuberculosis kills one in five people with HIV?
For the first time a dedicated hub for discussing the deadly duo of TB+HIV will feature in the Global Village, which is open to the public.
The TB+HIV Networking Zone is hosted by Burnet and our partners. Come along to hear more about the way forward in tackling these deadly diseases.
Hear about Burnet’s work and meet our staff on:
- Tuesday 22 July, 3pm-4pm - Meet the Experts
Point-of-care tests for TB and HIV - progress, challenges and future directions.
- Wednesday 23 July, 1.00pm-1.40pm - Case Study
Integrating TB and HIV care in Myanmar. Experiences from the field.
- Thursday 24 July, 1.00pm-1.40pm - Panel Discussion
Living with drug-resistant TB, living with HIV, health, human rights and new global plagues.
The substantial progress made in the fight against HIV over past years is threatened by the neglect of tuberculosis (TB). By ignoring TB, we risk undermining the huge financial investments made to help people living with HIV. We must work in partnership to increase political commitment and funding to the fight against TB and TB-HIV, and ensure all people can access the TB-HIV services they need.
Overcoming the deadly duo:TB + HIV
TB is the leading killer of people living with HIV, causing one in five HIV-related deaths.
TB is the most common presenting illness among people living with HIV, including those who are taking antiretroviral treatment.
At least one-third of the 35 million people living with HIV is infected with latent TB, and those co-infected with TB and HIV are 21-34 times more likely to develop active TB.
Around 75 per cent of co-infected patients live in the African region.
US$600 million a year is needed to implement collaborative TB/HIV activities, such as increased testing for TB among people living with HIV. This excludes antiretroviral treatment (ART) for TB patients living with HIV.
Visit the TB+HIV website.